2m 2m 2m 2m 2m 2m 2m
AVALO THERAP (AVTX)
NASDAQ
$13.90-$0.06 (-0.43%)
Price as of Jun 03, 2026 7:30 PM EDT- $838.4MMarket Cap
- 217.27%1-Year Change
- BiotechnologyIndustry
AVALO THERAP (AVTX)
$13.90-$0.06 (-0.43%)
AVTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.96 | ||
Change | -$1.79 (-11.37%) | ||
Open | $15.44 | ||
High | $15.62 | ||
Low | $13.78 | ||
Previous Close | $15.75 | ||
Volume | 1,604,169 | ||
30-Day Average Volume | 2,868,577 | ||
1-Week Change | -12.86% | ||
1-Month Change | 1.82% | ||
1-Year Change | 217.27% | ||
3-Year Change | -97.99% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 52.6M | ||
Total Assets | $99.9M | ||
Market Cap | $838.4M | ||
Enterprise Value | $813.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$19.6M | ||
Free Cash Flow | -$25.2M | ||
EBIT | -$19.6M | ||
EBITDA | -$19.6M | ||
Net Working Capital | $77.2M | ||
EPS | -$0.98 | ||
Enterprise Value/EBITDA | -41 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 12 | ||
P/E | -16 | ||
PEG | 1 | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -47 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 240 | ||
Last Split Date | 12/29/2023 | ||
Earnings & Revenue